Skip to content
The role of the patient voice in CMS drug price ‘negotiation’
The Centers for Medicare & Medicaid Services (CMS) recently announced the 2025 selection ...
Read More
BIO celebrates release of FDA Rare Disease Innovation Hub 2025 strategic plan
February 28 is Rare Disease Day, and in observance, the Biotechnology Innovation Organization ...
Read More
Goodwin Rare Disease Symposium: ‘So much opportunity, so much unmet need’
Drug development in the rare disease space has seen a vast amount of ...
Read More
FFA Week promotes careers in biotech for agriculture
Beyond inspiring tomorrow’s farmers, FFA (formerly Future Farmers of America) also promotes careers ...
Read More
M&A comeback may face political headwinds, say BIO CEO panelists
When it comes to biotech M&A, 2024 wasn’t a great year, but it ...
Read More
BIO promotes its partnership with farmers and ranchers at Farm Bureau Convention
As farmers, ranchers, and biotech companies work together to keep America strong and ...
Read More
EDITORS' CHOICE
What BIO’s watching in the new Congress
Reforms to prevent middlemen from driving up drug prices and legislation encouraging the development of oral medications and rare disease treatments were called top priorities ...
Read More
LATEST NEWS
Federal Policy
Why reauthorization of the Rare Pediatric Disease Priority Review Voucher (PPRV) Program is vital
The Food and Drug Administration’s (FDA) Rare Pediatric Disease Priority Review Voucher (PPRV) Program was top of mind during BIO’s March Patient Advocacy Coffee Chat: ...
Agriculture
National Biobased Products Day: Building better with biology
Whether it’s bottles, baby wipes, fashion, or fuel, biology can build it better. Biobased products, made from renewable natural materials, provide sustainable alternatives to products ...
Diversity, Equity, Inclusion
International Women’s Day: Improving women’s health by addressing autoimmune disease
March 8th is International Women’s Day and to mark the occasion, Bio.News is exploring an under researched field of women’s health – autoimmune diseases – ...
Federal Policy
House members urge passage of reforms at PBM hearing
The time has come for Congress to pass legislation to prevent pharmacy benefit managers (PBMs) from inflating drug costs, limiting patient access to drugs, and ...
Health
EPIC Act introduced to correct IRA’s ‘pill penalty’
Bipartisan legislation reintroduced in the House on Feb. 21 would encourage the development of small-molecule drugs by eliminating the “pill penalty” in the Inflation Reduction ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
AGRICULTURE
Climate Change
Combatting misinformation on biotechnology in food
Biotechnology’s role in enhancing food security while addressing climate change is gaining deserved attention. It is important that we understand ...
Read More
Federal Policy
State Policy
John Crowley highlights Colorado’s biotech ecosystem during packed Denver tour
Colorado’s contributions to biotechnology innovation—and biotech’s importance to our health, food supply, and national security—were key themes as BIO President ...
Read More
International
Bio's View
BIO celebrates release of FDA Rare Disease Innovation Hub 2025 strategic plan
February 28 is Rare Disease Day, and in observance, the Biotechnology Innovation Organization (BIO) is highlighting how it is working ...
Read More
